Tonix Pharmaceuticals Announces that Breakthrough Therapy Designation Remains in Effect for Tonmya(r) for the Treatment of Posttraumatic Stress Disorder

Source :: Plus Company Updates. April 23, 2019
Publication Year :: 2019
Abstract: UNITED STATES: Tonix Pharmaceuticals Holding Corp. has issued the following press release: Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company developing pharmaceutical products to [...]

Subjects :: Biological products
Cyclobenzaprine
Post-traumatic stress disorder
Backup software
Pain management
Biological weapons
Pharmaceutical industry
Bioterrorism
General interest
News, opinion and commentary

Tools